Table 3.
AEs in the HCQ and systemic CS groups
| HCQ group (n = 39) | CS group (n = 39) | P value | |
|---|---|---|---|
| Total AEsa | 5 (12.8%) | 12 (30.8%) | 0.055 |
| Pneumonia | 0 (0) | 1 (2.6%) | |
| Gastrointestinal infection | 0 (0) | 1 (2.6%) | |
| Newly diagnosed diabetes | 0 (0) | 1 (2.6%) | |
| Arthralgia | 0 (0) | 3 (7.7%) | |
| Palpitations | 1 (2.5%) | 3 (7.7%) | |
| Increase of liver enzymes | 0 (0) | 2 (5.1%) | |
| Nausea | 2 (5.1%) | 0 (0) | |
| Insomnia | 0 (0) | 1 (2.6%) | |
| Skin pigmentation | 2 (5.1%) | 0 (0) |
Multiple occurrences of the same AE in one person were only counted once
Abbreviations: AEs adverse events, ALT alanine aminotransferase
a Number of patients with at least one event